João Ramalheira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
João Ramalheira has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
João Lopes
Serviço de Neurofisiologia, Hospital de Santo António, Centro Hospitalar do Porto, Largo Prof. Abel Salazar, 4099-003 Porto, Portugal
3 shared publications- António Martins da Silva
Unidade Local de Saúde de Santo António – Porto, Portugal; ICBAS (Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto), Porto, Portugal
2 shared publications - Bárbara Leal
Unit for Multidisciplinary Research in Biomedicine Abel Salazar Biomedical Sciences Institute–University of Porto Porto Portugal
2 shared publications João Chaves
Serviço de Neurologia, Hospital de Santo António, Centro Hospitalar e Universitário do Porto, Largo Prof. Abel Salazar, 4099-003 Porto, Portugal
2 shared publications- Paulo Pinho Costa
Unit for Multidisciplinary Research in Biomedicine (UMIB), Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto (UP), Porto, Portugal; Department of Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Porto, Portugal
2 shared publications Rui Rangel
Serviço de Neurocirurgia, Hospital de Santo António, Centro Hospitalar e Universitário do Porto, Largo Prof. Abel Salazar, 4099-003 Porto, Portugal
2 shared publications
Latest Publications
- 3 August 2018
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 5 (6) , 645-648
Late‐onset Levodopa Responsive Parkinsonism Due to Polymerase γ 1 Mutations
- 3 August 2018
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 5 (6) , 645-648
Late‐onset Levodopa Responsive Parkinsonism Due to Polymerase γ 1 Mutations
- 1 December 2017
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 313, 82-88
Brain expression of inflammatory mediators in Mesial Temporal Lobe Epilepsy patients
- 1 December 2017
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 313, 82-88
Brain expression of inflammatory mediators in Mesial Temporal Lobe Epilepsy patients
- 3 November 2017
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 128 (4) , 305-310
Immunogenetic predisposing factors for mesial temporal lobe epilepsy with hippocampal sclerosis
Purpose: Neuroinflammation appears as an important epileptogenic mechanism. Experimental and clinical studies have demonstrated an upregulation of pro-inflammatory cytokines such as IL-1β and TNF-α, in mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS). Expression of these cytokines can be modulated by polymorphisms such as rs16944 and rs1800629, respectively, both of which have been associated with febrile seizures (FS) and MTLE-HS development. The human leukocyte antigen (HLA) system has also been implicated in diverse epileptic entities, suggesting a variable role of this system in epilepsy. Our aim was to analyse the association between immunogenetic factors and MTLE-HS development. For that rs16944 (-511 T>C, IL-1β), rs1800629 (-308 G>A, TNF-α) polymorphisms and HLA-DRB1 locus were genotyped in a Portuguese Population. Methods: We studied 196 MTLE-HS patients (108 females, 88 males, 44.7 ± 12.0 years, age of onset = 13.6 ± 10.3 years, 104 with FS antecedents) and 282 healthy controls in a case–control study. Results: The frequency of rs16944 TT genotype was higher in MTLE-HS patients compared to controls (14.9% in MTLE-HS vs. 7.7% in controls, p = 0.021, OR [95% CI] = 2.20 [1.13–4.30]). This association was independent of FS antecedents. No association was observed between rs1800629 genotypes or HLA-DRB1 alleles and MTLE-HS susceptibility. Also, no correlation was observed between the studied polymorphisms and disease age of onset. Conclusion: The rs16944 TT genotype is associated with MTLE-HS development what may be explained by the higher IL-1β levels produced by this genotype. High IL-1β levels may have neurotoxic effects or imbalance neurotransmission leading to seizures.
- 3 November 2017
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 128 (4) , 305-310
Immunogenetic predisposing factors for mesial temporal lobe epilepsy with hippocampal sclerosis
Purpose: Neuroinflammation appears as an important epileptogenic mechanism. Experimental and clinical studies have demonstrated an upregulation of pro-inflammatory cytokines such as IL-1β and TNF-α, in mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS). Expression of these cytokines can be modulated by polymorphisms such as rs16944 and rs1800629, respectively, both of which have been associated with febrile seizures (FS) and MTLE-HS development. The human leukocyte antigen (HLA) system has also been implicated in diverse epileptic entities, suggesting a variable role of this system in epilepsy. Our aim was to analyse the association between immunogenetic factors and MTLE-HS development. For that rs16944 (-511 T>C, IL-1β), rs1800629 (-308 G>A, TNF-α) polymorphisms and HLA-DRB1 locus were genotyped in a Portuguese Population. Methods: We studied 196 MTLE-HS patients (108 females, 88 males, 44.7 ± 12.0 years, age of onset = 13.6 ± 10.3 years, 104 with FS antecedents) and 282 healthy controls in a case–control study. Results: The frequency of rs16944 TT genotype was higher in MTLE-HS patients compared to controls (14.9% in MTLE-HS vs. 7.7% in controls, p = 0.021, OR [95% CI] = 2.20 [1.13–4.30]). This association was independent of FS antecedents. No association was observed between rs1800629 genotypes or HLA-DRB1 alleles and MTLE-HS susceptibility. Also, no correlation was observed between the studied polymorphisms and disease age of onset. Conclusion: The rs16944 TT genotype is associated with MTLE-HS development what may be explained by the higher IL-1β levels produced by this genotype. High IL-1β levels may have neurotoxic effects or imbalance neurotransmission leading to seizures.
- 1 May 2014
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 18 (3) , 449-452
Resective surgery in the treatment of super-refractory partial status epilepticus secondary to NMDAR antibody encephalitis
- 1 May 2014
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 18 (3) , 449-452
Resective surgery in the treatment of super-refractory partial status epilepticus secondary to NMDAR antibody encephalitis